Shibata Nobuhiro, Eto Tada-Aki, Hotokezaka Masayuki, Iwamura Takeshi, Chijiiwa Kazuo
Dept of Surgery I, Miyazaki University School of Medicine.
Gan To Kagaku Ryoho. 2005 Aug;32(8):1159-62.
A 43-year-old woman who complained of abdominal fullness, appetite loss, and constipation was diagnosed as unresectable advanced schirrhous gastric cancer with left supra-clavicular lymph node metastases, massive ascites, rectal stenosis, and bilateral hydronephrosis due to peritoneal metastases. The biopsy specimen showed a poorly differentiated adenocarcinoma with signet-ring cells. After placement of the bilateral ureteral stents, she was treated with combined chemotherapy of biweekly paclitaxel (120 mg/m2, day 1, day 15) and TS-1 (80 mg/day, days 1-14 with 2-weeks rest). Subjective symptoms were relieved after one course of the chemotherapy. After 3 courses, computed tomography showed markedly reduced supra-clavicular lymph node metastases and no ascites. Radiographic and endoscopic examinations also demonstrated remarkable improvements in compliance of the gastric and rectal walls. These findings suggested that partial response on Response Evaluation Criteria in Solid Tumors (RECIST) was obtained. After the first course, the treatment was continued on an outpatient basis. There were no adverse effects over grade 2 throughout six courses of the chemotherapy. The biweekly paclitaxel and TS-1 chemotherapy may well be an effective treatment for advanced schirrhous gastric cancer with carcinomatous peritonitis.
一名43岁女性,主诉腹胀、食欲减退和便秘,被诊断为无法切除的晚期硬化型胃癌,伴有左锁骨上淋巴结转移、大量腹水、直肠狭窄以及因腹膜转移导致的双侧肾积水。活检标本显示为印戒细胞型低分化腺癌。在置入双侧输尿管支架后,她接受了每两周一次的紫杉醇(120mg/m²,第1天、第15天)和替吉奥(80mg/天,第1 - 14天,休息2周)联合化疗。化疗一个疗程后,主观症状得到缓解。3个疗程后,计算机断层扫描显示锁骨上淋巴结转移明显减少且无腹水。影像学和内镜检查也显示胃壁和直肠壁的顺应性有显著改善。这些结果提示达到了实体瘤疗效评价标准(RECIST)中的部分缓解。第一个疗程后,治疗改为门诊进行。整个六个疗程的化疗中,不良反应均未超过2级。每两周一次的紫杉醇和替吉奥化疗可能是治疗晚期硬化型胃癌伴癌性腹膜炎的有效方法。